ARCHIVES

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

ACS To Offer 10 Nurse Scholarships

July 18, 1980

Fox Chase-U.Pa. Radiation Dept. Received Contract

October 12, 1979

NCI Management Director Leaving For Case Institute.

October 12, 2001

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995

Age Doesn’t Affect Survival After Bone Marrow Transplant

December 26, 2008

In Brief: Search Narrows ACS Head; Selections For Breast Cancer Commission Still At HHS

March 27, 1992